These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2566217)

  • 1. [Side effects of psychopharmacotherapy in patients with schizophrenia proceeding against a background of organic cerebral insufficiency].
    Niss AI; Seid-Rzaev SM; Trubkovich MIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):91-5. PubMed ID: 2566217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of attack-like forms of schizophrenia in patients with residual cerebral organic insufficiency].
    Avrutskiĭ GIa; Niss AI; Trubkovich MIa; Seid-Rzaev SM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(1):105-10. PubMed ID: 1970447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unwanted effects of long-term medication in schizophrenia and depression.
    Pare CM
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):187-92. PubMed ID: 10587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enhanced sensitivity to psychotropic preparations and its relation to organic brain insufficiency].
    Niss AI; Trubkovich MIa; Seid-Rzaev SM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(5):114-9. PubMed ID: 3414263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment.
    Gerlach J
    J Clin Psychiatry; 1999; 60 Suppl 23():20-4. PubMed ID: 10625196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complications of combined use of lithium salts and neuroleptics in patients with endogenous psychoses].
    Mosolov SN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(3):115-21. PubMed ID: 6134409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2D6 genotype predicts antipsychotic side effects in schizophrenia inpatients: a retrospective matched case-control study.
    Kobylecki CJ; Jakobsen KD; Hansen T; Jakobsen IV; Rasmussen HB; Werge T
    Neuropsychobiology; 2009; 59(4):222-6. PubMed ID: 19521114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel versus conventional antipsychotic drugs.
    Love RC
    Pharmacotherapy; 1996; 16(1 Pt 2):6-10. PubMed ID: 8778684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Testing basic visual functions in the evaluation of extrapyramidal side effects of antipsychotic agents].
    Kéri S; Antal A; Szekeres G; Szendi I; Kovács Z; Janka Z; Benedek G
    Orv Hetil; 1998 Feb; 139(5):235-8. PubMed ID: 9489377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Resistant schizophrenia: what chemotherapy?].
    Vanelle JM
    Ann Med Psychol (Paris); 1993 Apr; 151(4):346-51. PubMed ID: 7904434
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influences of second generation antipsychotics on the course of schizophrenia].
    Messer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S161-3. PubMed ID: 15570540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG; Kopala LC; Rabinowitz J
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Various methods of overcoming resistance to therapy in childhood and adolescent schizophrenia].
    Antropov IuF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(10):1522-6. PubMed ID: 6118983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-extrapyramidal motor side-effects in long-term therapy with neuroleptics: an analysis of 99 patients].
    Ginzel I; Hilger E; Barnas C
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):38-43. PubMed ID: 12407934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment of schizophrenia.
    Hollister LE
    Psychiatr Clin North Am; 1984 Sep; 7(3):435-52. PubMed ID: 6148741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol.
    Kim JH; Byun HJ
    J Clin Pharm Ther; 2007 Oct; 32(5):461-7. PubMed ID: 17875112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amoxapine as an antipsychotic: comparative study versus haloperidol.
    Chaudhry IB; Husain N; Khan S; Badshah S; Deakin B; Kapur S
    J Clin Psychopharmacol; 2007 Dec; 27(6):575-81. PubMed ID: 18004123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drugs for schizophrenia: an update for family physicians.
    Amadio PB; Cross LB; Amadio P
    Am Fam Physician; 1997 Sep; 56(4):1149-56, 1159-60. PubMed ID: 9310066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of psychopharmacotherapy in improving the long-term outcome of schizophrenia.
    Alam DA; Janicak PG
    Essent Psychopharmacol; 2005; 6(3):127-40. PubMed ID: 15869020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.